ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Fund Grants To Increase Minority Internet Access.

October 6, 2000

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

In Brief: Newell Tells Advisory Committee It Isn’t a Lobbying Group, “Accept What We Give You”

April 8, 1977

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013